TY  - GEN
AU  - Jankowski,Joachim
AU  - Noels,Heidi
AU  - Jankowski,Joachim
AU  - Noels,Heidi
TI  - Comorbidities in Chronic Kidney Disease (CKD)
SN  - books978-3-03936-669-9
PY  - 2021///
CY  - Basel, Switzerland
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - Medicine
KW  - bicssc
KW  - arterial stiffness
KW  - carotid-femoral pulse wave velocity
KW  - hemodialysis
KW  - p-cresyl sulfate
KW  - uremic toxins
KW  - arterial calcification
KW  - lipid metabolism
KW  - inflammation
KW  - coagulation
KW  - endothelial dysfunction
KW  - epigenetics
KW  - chronic kidney disease
KW  - uremic cardiopathy
KW  - left ventricular hypertrophy
KW  - phosphate
KW  - PTH
KW  - FGF23
KW  - klotho
KW  - sclerostin
KW  - chronodisruption
KW  - chronodisruptor
KW  - circadian rhythm
KW  - internal clock
KW  - uremia
KW  - uremic cardiomyopathy
KW  - organ crosstalk
KW  - cardiorenal syndrome
KW  - left-ventricular hypertrophy
KW  - heart failure
KW  - cardiac fibrosis
KW  - cardiovascular disease
KW  - vascular calcification
KW  - experimental rodent models
KW  - FGFG23
KW  - Klotho
KW  - Wnt/β-catenin
KW  - CKD
KW  - parathyroid hormone
KW  - secondary hyperparathyroidism
KW  - uremic toxin
KW  - ageing
KW  - end-stage kidney disease
KW  - premature ageing
KW  - senescence
KW  - bone
KW  - gut
KW  - cardiovascular
KW  - CKD-MBD
KW  - comorbidity
KW  - fibrosis
KW  - calcification
N1  - Open Access
N2  - With a mean worldwide prevalence of 13%, chronic kidney disease imposes a massive health burden on our society. In addition to reduced kidney function, patients with chronic kidney disease increasingly suffer from cardiovascular diseases affecting the heart and vasculature. Cardiovascular diseases account for around half of the deaths of patients with advanced chronic kidney disease. However, therapeutic options are highly insufficient. The pathological mechanisms that underlie increased cardiovascular risk in patients with chronic kidney disease remain largely unknown. This Special Issue provides insights into comorbidities in CKD patients, mainly focused on increased cardiovascular risk, and summarizes current knowledge of underlying pathophysiological mechanisms
UR  - https://mdpi.com/books/pdfview/book/3437
UR  - https://directory.doabooks.org/handle/20.500.12854/68421
ER  -